ERBB2 and cancer: Mucinases, or bacterial mucin-selective proteases, offer a unique approach to specifically degrade mucins.78,79 Paralleling the antibody-sialidase work, we fused an engineered mucinase to an anti-HER2 nanobody to specifically degrade mucins on cancer cells.